Procyon's Shareholders Approve Merger Via Acquisition with Cellpep S.A.
Following the closing of the acquisition and concurrent financing, which is expected on or about March 1, 2006, the name of Procyon Biopharma Inc. will be changed to Ambrilia Biopharma Inc. and its shares will continue to trade on the Toronto Stock Exchange under the new ticker symbol AMB.
The approved share consolidation within a range of five to ten would occur at a later date during the year, as it is the intention of the Company to consolidate its shares following an information campaign and the attainment of certain corporate milestones during the year 2006.
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.